Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM10 | O14672 | 20/20 | 0.79 |
| ▸ | MMP2 | P08253 | 17/20 | 0.79 |
| ▸ | ERBB2 | P04626 | 9/20 | 0.79 |
| ▸ | MMP9 | P14780 | 11/20 | 0.72 |
| ▸ | MMP3 | P08254 | 5/20 | 0.72 |
| ▸ | MMP12 | P39900 | 2/20 | 0.55 |
| ▸ | MMP14 | P50281 | 2/20 | 0.55 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.55 |
| ▸ | ADAM33 | Q9BZ11 | 2/20 | 0.55 |
| ▸ | ADAM8 | P78325 | 1/20 | 0.55 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP7 | P09237 | 1/20 | 0.50 |
| ▸ | MMP8 | P22894 | 1/20 | 0.50 |
| ▸ | ADAM9 | Q13443 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3648643 | 1.00 | ADAM10 (0.79) | ADAM10MMP2ERBB2MMP9MMP3 | |
| Aderbasib SCHEMBL206421 | 0.90 | ADAM10 (0.76) | ADAM10MMP2ERBB2MMP9MMP3 | |
| Aderbasib SCHEMBL1366560 | 0.90 | ADAM10 (0.76) | ADAM10MMP2ERBB2MMP9MMP3 | |
| SCHEMBL3543143 | 0.89 | ADAM10 (0.62) | ADAM10MMP2ERBB2MMP9MMP3 | |
| SCHEMBL1366079 | 0.88 | ADAM10 (1.00) | ADAM10MMP2ERBB2MMP9MMP3 | |
| SCHEMBL1365111 | 0.88 | ADAM10 (1.00) | ADAM10MMP2ERBB2MMP9MMP3 | |
| SCHEMBL2530093 | 0.87 | ADAM10 (0.72) | ADAM10MMP2ERBB2MMP9MMP3 | |
| SCHEMBL2528026 | 0.87 | ADAM10 (0.72) | ADAM10MMP2ERBB2MMP9MMP3 | |
| SCHEMBL1366083 | 0.86 | ADAM10 (0.71) | ADAM10MMP2ERBB2MMP9MMP3 | |
| SCHEMBL1366801 | 0.86 | ADAM10 (0.71) | ADAM10MMP2ERBB2MMP9MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1622569-B1 | AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLPROTEASES | INCYTE CORP (US) | 2015-12-02 | — | — | EP | claimed |
| EP-1951242-A2 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | Incyte Corporation (US) | 2008-08-06 | — | — | EP | claimed |
| WO-2007062093-A2 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER COMPRISING A METALLOPROTEASE INHIBITOR | INCYTE CORPORATION (US) | 2007-05-31 | — | — | WO | claimed |
| EP-3020402-A1 | AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLPROTEASES | Incyte Holdings Corporation (US) | 2016-05-18 | — | — | EP | disclosed |